Navigation Links
UPDATE: China PharmaHub Corp. Introduces a 'Magic Bullet' Liver Cancer Therapy to China, Hong Kong, Taiwan, Macau, Singapore, Malaysia, and Bangladesh
Date:8/26/2010

therapy combats tumors in patients with hepatocellular carcinoma (HCC), commonly known as primary liver cancer, who cannot be treated with surgery, and are awaiting an organ transplant.

As the exclusive distributor in the Greater China Region, Singapore, Malaysia and Bangladesh of this new form of liver cancer treatment, PharmaHub believes that the therapy offers a solution to the problem of malignant liver cancer in Southeast Asia where approximately three-quarters of the cases of liver cancer worldwide are found. China, alone, has the highest number of liver cancer patients worldwide, approximately one-half of the world HCC population, with more than 350,000 new cases diagnosed each year, a number that is expected by Management to continue to rise in the coming years. As projected by IMS Health, China will become the world's third-largest pharmaceutical market by 2011, growing by more than 20% annually. Oncology is among the top five therapy classes in China, which recorded a staggering 27% compound annual growth rate ("CAGR") from 2005-2009 and is poised to achieve similar gains through 2015.

Richard Lui, CEO of PharmaHub stated, "We are thrilled with this opportunity to take a leadership role in introducing this type of radioembolization treatment for inoperable liver cancer in China and Southeast Asia. This therapy is a pioneering alternative to surgery, chemotherapy and other radiation therapies in current usage. Overall, the treatment can cause fewer and milder side effects than other current treatments and offers the convenience of outpatient therapy at a significantly lower price than the more conventional treatments."

"PharmaHub plans to immediately set up clinical studies in China to test wider applications of the medical technology, not only for liver but other cancers, then move to commercialization of the procedure in a cost-effective and reliable manner throughout China," stated Mr. Lui.   "We also foresee the potential medic
'/>"/>

SOURCE China PharmaHub Corp.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. UPDATE: Nile Therapeutics Announces Positive Phase 1a Results of CD-NP, a Selective NPR-B Agonist in Clinical Development for the Treatment of Heart Failure
2. UPDATE: New Report by Pediatricians Finds Gaps in Preparing to Protect Kids From Pandemic Flu, Offers Recommendations
3. UPDATE: Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
4. UPDATE: Infant Primates Given Vaccines on U.S. Childrens Immunization Schedule Develop Behavioral Symptoms of Autism
5. ELADUR(TM) Development Update: DURECT Receives Orphan Drug Designation for Bupivacaine for Post-Herpetic Neuralgia
6. UPDATE: US Oncology Research Network Participates in Phase III Follow-up Study to BiPars Investigational Cancer Drug BSI-201
7. UPDATE: FDA Issues 22 Warning Letters to Web site Operators
8. Update: International HIV/AIDS Partnership Wins Two Awards for Supply Chain Excellence
9. HUYA Bioscience Intl Announces Clinical Trial Milestones in China for Promising New Anti-Arrhythmic Compound; Data Supports Desirable Safety Profile
10. HUYA Bioscience Intl Announces World-Class Clinical Advisory Team for New Anti-Arrhythmic Compound Sourced From China
11. HUYA Bioscience Intl Announces First Pre-IND Outcome for a Development Stage Compound Sourced From China - HBI-8000, Promising New Cancer Compound
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... 2015   InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" ... ("EPS"), today announced that its CGuard TM Embolic Prevention ... Prof. Piotr Musialek , at the EuroPCR ... . PARADIGM, an investigator-initiated P rospective ... roti D revascularization I n symptomatic and increased-risk ...
(Date:5/22/2015)... , May 22, 2015 AcelRx Pharmaceuticals, Inc. ... on the development and commercialization of innovative therapies for ... that interim chief executive officer Howie Rosen ... chief financial officer Tim Morris will be ... the two presentations are as follows: Jefferies ...
(Date:5/21/2015)... May 21, 2015 Research ... addition of the "Market Assessment of Respiratory ... report to their offering. ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ... respiratory imaging diagnostics market in the ... . The service provides detailed analysis of ...
Breaking Medicine Technology:InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 2InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 3InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 4AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences In June 2United States and Europe Respiratory Diagnostics Market Assessment 2015 2
... 20 Cardiac Science Corporation (Nasdaq: ... ( AED ) and diagnostic cardiac monitoring devices, ... vital signs and spot check monitors ... Canada. OMRON Healthcare is a subsidiary of OMRON Corporation, the ...
... SHENYANG, China, Oct. 20 /PRNewswire-Asia-FirstCall/ -- ... leading China-based biotechnology,company focused on researching, developing, manufacturing and ... general,meeting of shareholders held on October 12, 2009. , ... shareholders re-elected Dr. Jing Lou and Mr.,Moujia Qi to ...
Cached Medicine Technology:Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 2Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 3Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 4Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 6
(Date:5/25/2015)... 26, 2015 According to the National Library ... pigmentosa , a degenerative eye disease. The National Library of ... paroxysmal kinesigenic dyskinesia , a rare disorder that causes ... K. Chan , these two diseases are more than a ... walk in his shoes with his new autobiography “ ...
(Date:5/25/2015)... The National Association of Professional Women ... a 2015-2016 inductee into its VIP Woman of the ... for leadership in biomedical engineering. NAPW is the nation's ... than 700,000 members and over 200 operating Local Chapters. ... group of professional women," said NAPW President Star Jones. ...
(Date:5/25/2015)... 25, 2015 According to a recently ... growth in hip external fixation market is driven by ... population and advancements in infection prevention technologies. As the ... are currently accounting for the largest total number of ... falls and accidents. As a result, the average selling ...
(Date:5/25/2015)... (PRWEB) May 25, 2015 Join Fiona's Soccer ... free two-hour instructional clinic. Irish National Player, Fiona O'Sullivan ... give them a taste of her coaching style. Fiona has ... Novato. Camps in Novato are at Lynwood Elmentary School (June ... Novato High School - June 6th, 2015 - 1:00-3:00pm. Bring ...
(Date:5/24/2015)... Pacific Prime has announced that they have launched the second ... of individual international health insurance. Titled: The Cost of Health Insurance ... health insurance in six top expat destinations, which are also popular ... Kong , Singapore , China , ... UK , Article 2 presents an in-depth look at ...
Breaking Medicine News(10 mins):Health News:Joseph K. Chan Finds Faith from Disability in New Autobiography 2Health News:National Association of Professional Women Inducts Lisa Ferrara, Ph.D., CEO of OrthoKinetic Technologies, Into its VIP Professional Woman of the Year Circle 2Health News:DePuy Synthes and Stryker Lead Orthopedic External Fixation Trauma Device Market Due to Increased Hip Fractures in the U.S. 2Health News:DePuy Synthes and Stryker Lead Orthopedic External Fixation Trauma Device Market Due to Increased Hip Fractures in the U.S. 3Health News:US Sports Camps and Nike Soccer Camps Offer Complimentary Instructional Clinic with Fiona's Soccer Camp 2Health News:Pacific Prime Releases 2nd Article of Cost of Health Insurance Report 2
... TUESDAY, Jan. 4 (HealthDay News) -- Just weeks after U.S. ... to treat breast cancer, a new study provides more evidence ... failure in these patients. The meta-analysis, published online Jan. ... almost 4,000 patients and found a small but significant number ...
... Researchers have produced a lasting anti-cocaine immunity in mice by ... cold virus with a particle that mimics cocaine. , ... the online edition of Molecular Therapy and funded by ... strategy might be the first to offer cocaine addicts a fairly ...
... Jan. 4 (HealthDay News) -- Elderly people who lose their ... found. The new study included more than 4,000 Japanese ... a psychiatric assessment. Compared with participants who still had many ... were much more likely to have experienced some memory loss ...
... January 2011 - Normally, cortical nerve cells or neurons reside ... neurons in the white matter, but some people with schizophrenia ... Neuronal migration errors may arise in schizophrenia as a consequence ... of aberrant cellular localization has now been studied in detail ...
... Rochelle, NY, January 4, 2011Lowering the body temperature of ... injury may reduce neurologic complications and improve outcomes. The ... has been demonstrated in national studies. According to a ... and how it is administered should depend on the ...
... (January 4, 2011) -- Cumbersome glaucoma tests requiring a ... to a home test developed by an engineer at ... involving a system of micro-force sensors, specially designed microchips, ... at the UA College of Engineering. The easy-to-use probe ...
Cached Medicine News:Health News:More Evidence Links Avastin to Heart Failure in Breast Cancer Patients 2Health News:More Evidence Links Avastin to Heart Failure in Breast Cancer Patients 3Health News:Vaccine blocks cocaine high in mice 2Health News:Vaccine blocks cocaine high in mice 3Health News:Neuronal migration errors: Right cells, wrong place 2Health News:Optimizing patient outcomes after therapeutic hypothermia for traumatic brain injury 2Health News:New glaucoma test allows earlier, more accurate detection 2
... its name from its first known site ... majority of PSA circulates bound to anti-chymotrypsin ... of PSA are elevated in patients with ... prostatitis [1-3]. In addition, PSA serum levels ...
... profitability by reducing ... simple test,sequences that ... by ancillary office ... 5 minutes. New ...
... as a Valuable Tool for Measuring ... Eye Disease. Near Test F.A.C.T. 101: ... (12.7cm x 17.78cm) Can be Hand-Held ... F.A.C.T. 201: Size 27 in ...
Adult: Letter Monocular Acuity, Binocular Astigmatism, Acuity Balance, Supression, Binocular Acuity, Fixation Desparity, Muscle Balance, Stereopsis...
Medicine Products: